Petrelintide in Genentech’s Phase II ZUPREME-1 Trial: Meaningful Weight Loss, Slower Titration, and What Still Needs Proof
Genentech’s Phase II ZUPREME-1 trial suggests petrelintide is not a quick fix, but it may become a useful long-term obesity…
Genentech’s Phase II ZUPREME-1 trial suggests petrelintide is not a quick fix, but it may become a useful long-term obesity…